| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $9.1M | +105.3% |
| Cost of Revenue | $23.7M | +141.0% |
| Gross Profit | -$14.7M | -169.8% |
| R&D Expense | $3.7M | +81.1% |
| SG&A Expense | $20.4M | +92.5% |
| Operating Income | -$38.7M | -114.6% |
| Pre-tax Income | -$36.8M | -112.2% |
| Income Tax | $0 | — |
| Net Income | -$36.8M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $45.8M | -34.3% |
| Accounts Receivable | $1.3M | +84.4% |
| Inventory | $730K | +46.0% |
| Current Assets | $50.5M | -32.8% |
| Total Assets | $107.7M | +29.5% |
| Current Liabilities | $13.5M | +94.5% |
| Total Liabilities | $47.9M | +372.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$25.6M | -84.1% |
| Capital Expenditures | $17.6M | +1085.0% |
| Investing Cash Flow | -$17.6M | -1085.0% |
| Financing Cash Flow | $19.2M | -74.0% |
| Free Cash Flow | -$43.1M | -180.6% |
| -112.2% |
| EPS (Basic) | -$0.43 | -79.2% |
| EPS (Diluted) | -$0.43 | -79.2% |
| Stockholders' Equity |
| $59.8M |
| -18.1% |